Researchers at the University at Buffalo (UB) are designing a new biomedical device that could make chemotherapy more efficient, reduce its side effects, and improve

Oral infection with the human papillomavirus (HPV) type most frequently linked to HPV-related head and neck cancers (HPV16) is more likely to persist at least

Selecta Biosciences has received a $3.2 million grant from the Skolkovo Foundation to develop an immunotherapy to treat cancers caused by the human papilloma virus

Research by scientists from the University of California, Los Angeles (UCLA) School of Dentistry could lead to a simple saliva test capable of diagnosing the

The risk of developing salivary gland cancer might be higher in people with mutations in either of two genes associated with breast and ovarian cancers,

Johns Hopkins researchers have developed blood and saliva tests that can accurately predict the recurrence of oropharyngeal squamous cell carcinoma (OPSCC) linked to human papillomavirus

Researchers at the Scripps Research Institute in Florida have made a clinical discovery that could help physicians develop new treatments for an oral cancer that

Mouse models of human oral cancer treated with capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, according to a new study in Oral

Missouri researchers have found a pattern of gene expression associated with aggressive tumors that could produce a diagnostic test that could alter the clinical management

U.S. researchers have developed a framework for exploiting the oral microbiome for monitoring oral cancer development, progression, and recurrence, according to a new article in

Doxepin rinse may prove to be an option to help relieve pain associated with oral mucositis in patients with head and neck cancers, according to